Achieve Life Sciences, Inc. Deferred Revenue
Achieve Life Sciences, Inc. (ACHV) had Deferred Revenue of $2.10 million as of 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-02-23
- 2016-03-31: Deferred Revenue, Current $2.10M.
- 2015-12-31: Deferred Revenue, Current $5.04M.
- 2015-09-30: Deferred Revenue, Current $11.04M.
- 2015-06-30: Deferred Revenue, Current $17.78M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2016-03-31 | $2.10M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $5.04M 10-K · filed 2017-02-23 |
| 2015-09-30 | $11.04M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $17.78M 10-Q · filed 2015-08-13 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-07 |
| 2012-09-30 | $9.14M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $15.37M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $17.34M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $18.27M 10-K · filed 2013-03-07 |
| 2011-09-30 | $10.00M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $10.00M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $10.00M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |